Dr. Joel Diamond
Dr. Joel Diamond, CMO of Aranscia, has extensive clinical and technology experience. He formerly served as CMIO and chairman of the Physician Advisory Board at the University of Pittsburgh Medical Center, St. Margaret Memorial Hospital, where he facilitated 100% adoption of CPOE in a community hospital. He helped develop dbMotion, a solution for health information exchange and population health. He is a diplomat of the American Board of Family Practice and a fellow in the American Academy of Family Physicians while continuing to care for patients at Handelsman Family Practice in Pittsburgh, PA.
-
MedCity Influencers, Devices & Diagnostics
Accelerating the Move to Precision Oncology
By continuing an open discussion on precision medicine and precision care, we can truly accelerate pharmacogenomic testing to its full potential and focus on providing the highest quality care to those who need it most.
-
MedCity Influencers, Devices & Diagnostics, Physicians
Precision medicine: A new dimension to improve care outcomes
All the hype around precision medicine can make it seem intimidating and foreign. The good news is that it does not represent a departure from current clinical practice, and it can significantly improve patient care.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
BioPharma, MedCity Influencers, SYN
Precision medicine can close care gaps to reduce incidence of cancer
As researchers and clinicians understand and embrace the advanced insights genetic and genomic testing can deliver, the industry is poised to dramatically reduce the incidence and mortality associated with cancers.
-
Health IT, MedCity Influencers
IT will be key to precision medicine’s success in 2020
Unless IT concerns related to precision medicine are addressed, healthcare will simply reenact a mistake made years ago with EHRS valuable data that can directly impact care will be locked in a silo, unavailable during clinical decision-making.
-
Don’t lock genomic data into silos
Healthcare leaders have an opportunity to build their infrastructure right this time – with foresight into how valuable genomic data will be to all their stakeholders, now and into the future.
-
MedCity Influencers, Diagnostics
Direct-to-consumer genetic testing: One size doesn’t fit all
Not all direct-to-consumer tests tell the truth, the whole truth, and nothing but the truth. So where do modern consumers stand?
Promoted
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
